Commit To Buy Merrimack Pharmaceuticals At $5, Earn 36% Annualized Using Options
July 31, 2014 at 11:29 AM EDT
Investors eyeing a purchase of Merrimack Pharmaceuticals Inc. (MACK) stock, but cautious about paying the going market price of $6.00/share, might benefit from considering selling puts among the alternative strategies at their disposal..
